对于已进行了手术的晚期肝癌患者，手术会影响索拉非尼的安全性和疗效吗？
For those patients with advanced HCC, who have had surgical resection, with the surgery impact the safety and efficacy of sorafenib?
国际肝病：大多数肝癌在诊断时已是晚期。HCC早期诊断的新分子标志有哪些？
International Digest: Most HCC is not diagnosed until the disease is at an advanced stage. What novel molecular markers are there for the early diagnosis for HCC?
目的：探讨薏苡仁提取物注射液对晚期原发性肝癌患者免疫功能的影响。
Objective To study the influence of KLT on immune function in patients with advanced primary hepatocarcinoma .
目的经肝动脉介入性灌注与热灌注化疗治疗中晚期肝癌，观察对比病灶大小、生存期。
Objective To observe and compare the volumes and survival periods of tumors in the patients with advanced liver cancer after treatments of transhepatic arterial infusion and heat infusion.
目的探讨康莱特注射液联合介入化疗栓塞治疗中、晚期原发性肝癌的疗效。
Objective To evaluate the efficacy of KanLaite injection combined with chemoembolization on primary middle and advanced stage liver cancer.
结论肝动脉局部灌注化疗对不能手术切除的晚期肝癌，作为治疗手段不失为一种有效的方法。
Conclusions the local infusion chemotherapy via hepatic artery and portal vein was an effective therapy for those who could not undergo the resection of advanced liver cancer.
目的：探讨健脾消积口服液对改善晚期肝癌患者生存质量的临床疗效。
Objective: To study clinical therapeutic effect of Jianpi Xiaoji Oral Liquid on life quality in patients of late liver cancer.
目的探讨腹腔化疗或联合其他方法综合治疗晚期原发性肝癌的治疗效果。
Objective to evaluate the effect of intraperitoneal chemotherapy or with other methods for treatment in patients with advanced primary liver cancer.
目的：探讨中、晚期肝癌变异、寄生性供血的产生机理。
Purpose: Study the mechanism of variation and parasitic blood supply in advanced hepatic cancers.
目的：观察苦参碱注射液配合TACE术治疗晚期肝癌的疗效及实验室指标的变化。
Objective:Observe the therapeutic effect and lab index changes of metaphase late liver cancer treated by matrine injection together with TACE operation.
目的：观察中医综合治疗方案治疗原发性中晚期肝癌的疗效。
Objective: to observe the effects of complex treatment with traditional Chinese medicine on advanced primary hepatocarcinoma.
国际肝病：最近有研究报道索拉非尼用于治疗晚期肝癌，主要是SHARP临床试验和亚太地区的试验。
HEPATOLOGY DIGEST: Recently there were reported studies on the efficacy of sorafenib in treating patients with advanced hepatocellular carcinoma mainly the SHARP trial and the Asia-Pacific study.
目的探讨晚期肝癌患者的临终护理特点。
Objective To explore the features of hospice care of patients with advanced stage of liver cancer.
结论癌肿姑息切除联合肝动脉置管埋泵化疗有助于提高中晚期肝癌患者的生存时间和生命质量。
Conclusions Palliative resection of liver cancer and implanted with a drug delivery system can improve survival duration and life quality of patients with advanced HCC.
目的观察肝动脉化疗栓塞联合无水乙醇注射治疗中晚期肝癌的疗效。
Objective To observe the clinical therapeutic effect of transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) in moderate or advanced liver cancer.
介入治疗是晚期肝癌的主要治疗手段，术后随访中及时、准确评价疗效是手术取得良好疗效的重要保证。
Interventional therapy is the main treatment of advanced liver cancer. Timely following-up and accurate evaluation after interventional therapy is of important value for good clinical efficacy.
因为大多数肝癌直到晚期才出现症状，他们大多数到诊断时已失去移植的机会。
Because liver cancers cause few symptoms until later stages, they are often not diagnosed until the opportunity for a transplant has passed.
目的分析TACE、PEI、PVC三介入联合治疗中晚期原发性肝癌的临床疗效。
Objective To explore the clinical efficacies of TACE, PEI, PVC, for advanced Liver cancer.
结论中晚期不能切除的原发性肝癌使用肝动脉、门静脉双重插管灌注化疗，可以改善临床症状、延长存活期。
Conclusion Double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma may ameliorate symptoms and prolong survival time.
目的探讨超声引导下局部治疗结合门静脉化疗在中晚期肝癌中的应用。
Objective To investigate the application of local treatment combining with chemotherapy via portal vein guided by US in advanced hepatic cancer.
探索介入化疗、局部注射TIL、瘤内无水酒精注射综合治疗晚期肝癌的疗效。
To probe into curative effect of comprehensively treating hepatocellular carcinoma by interventional chemotherapy, locally injecting TIL and injecting absolute alcohol into tumor.
目的：观察复方苦参注射液肝动脉灌注治疗中晚期肝癌的临床疗效。
Objective:To observe the clinical therapeutic of Prescription Radix Injection(PRI)hepatic arterial infusion therapy mid-late stage liver cancer.
亚砷酸全身化疗被认为对中晚期肝癌具有一定作用，但在肝移植后的应用还未见报道。
Arsenious acid chemotherapy is considered effective on treating moderate or advanced liver cancer, but its utilization following liver transplantation remains few.
结果说明，冷冻治疗中晚期肝癌有一定临床疗效，目前看来可以缓解症状，延长生命。
This result suggested that the frozen treatment for primary hepatic carcinoma in middle and advanced stage has definite palliative effect to relieve the symptoms and to prolong the live span.
HBV通常可以逃避早期和晚期免疫应答导致慢性肝脏疾病——慢性乙型肝炎、乙肝后肝硬化、肝衰竭、肝癌。
HBV can usually escape early and late immune response leading to chronic liver disease-chronic hepatitis B, liver cirrhosis, liver failure and hepatic cellular carcinoma.
目的评价姑息切除联合肝动脉置管埋泵在中晚期肝癌治疗中的作用。
Objective to evaluate the effect of palliative resection and implanted with a drug delivery system of advanced primary hepatocellular carcinoma (PHCC).
目的总结晚期肝癌并肝包膜下出血或肝破裂出血的护理要点。
Objective To summarize the nursing in patients with advanced liver carcinoma complicating liver capsule bleeding and liver bleeding.
目的总结晚期肝癌并肝包膜下出血或肝破裂出血的护理要点。
Objective To summarize the nursing in patients with advanced liver carcinoma complicating liver capsule bleeding and liver bleeding.
应用推荐